These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15908902)

  • 1. Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine.
    Kaufer DI; Borson S; Kershaw P; Sadik K
    CNS Spectr; 2005 Jun; 10(6):481-8. PubMed ID: 15908902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caregiver burden and prevalence of depression, anxiety and sleep disturbances in Alzheimer's disease caregivers in China.
    Liu S; Li C; Shi Z; Wang X; Zhou Y; Liu S; Liu J; Yu T; Ji Y
    J Clin Nurs; 2017 May; 26(9-10):1291-1300. PubMed ID: 27681477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2002; 20(13):919-42. PubMed ID: 12381243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of galantamine treatment on caregiver time in Alzheimer's disease.
    Sano M; Wilcock GK; van Baelen B; Kavanagh S
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):942-50. PubMed ID: 14533127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial.
    Rockwood K; Fay S; Song X; MacKnight C; Gorman M;
    CMAJ; 2006 Apr; 174(8):1099-105. PubMed ID: 16554498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease.
    Cummings JL; Schneider L; Tariot PN; Kershaw PR; Yuan W
    Am J Psychiatry; 2004 Mar; 161(3):532-8. PubMed ID: 14992980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.
    Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
    Int J Technol Assess Health Care; 2002; 18(3):497-507. PubMed ID: 12391943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the Caregiver Burden of Caring for Community-Residing People with Alzheimer's Disease.
    Yu H; Wang X; He R; Liang R; Zhou L
    PLoS One; 2015; 10(7):e0132168. PubMed ID: 26154626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer's disease: A narrative review.
    Isik AT; Soysal P; Solmi M; Veronese N
    Int J Geriatr Psychiatry; 2019 Sep; 34(9):1326-1334. PubMed ID: 30198597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of rivastigmine on caregiver burden associated with Alzheimer's disease in both informal care and nursing home settings.
    Grossberg GT
    Drugs Aging; 2008; 25(7):573-84. PubMed ID: 18582146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer's disease.
    Liu S; Liu J; Wang XD; Shi Z; Zhou Y; Li J; Yu T; Ji Y
    Int Psychogeriatr; 2018 Aug; 30(8):1131-1138. PubMed ID: 29223171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of patient and caregiver predictors for caregiver burden, anxiety and depression in Alzheimer's disease.
    Lou Q; Liu S; Huo YR; Liu M; Liu S; Ji Y
    J Clin Nurs; 2015 Sep; 24(17-18):2668-78. PubMed ID: 26108739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting caregiver burden and depression in Alzheimer's disease.
    Clyburn LD; Stones MJ; Hadjistavropoulos T; Tuokko H
    J Gerontol B Psychol Sci Soc Sci; 2000 Jan; 55(1):S2-13. PubMed ID: 10728125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment, measures and approaches to easing caregiver burden in Alzheimer's disease.
    Farcnik K; Persyko MS
    Drugs Aging; 2002; 19(3):203-15. PubMed ID: 12027778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The needs of the caregiver in the long-term treatment of Alzheimer disease.
    Bullock R
    Alzheimer Dis Assoc Disord; 2004; 18 Suppl 1():S17-23. PubMed ID: 15249844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.
    Monsch AU; Giannakopoulos P;
    Curr Med Res Opin; 2004 Jun; 20(6):931-8. PubMed ID: 15200752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: results from the MALT clinical trial. Metrifonate in Alzheimer's Disease Trial.
    Shikiar R; Shakespeare A; Sagnier PP; Wilkinson D; McKeith I; Dartigues JF; Dubois B
    J Am Geriatr Soc; 2000 Mar; 48(3):268-74. PubMed ID: 10733052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caregivers of Alzheimer's patients and factors influencing institutionalization of loved ones: some considerations on existing literature.
    Sansoni J; Anderson KH; Varona LM; Varela G
    Ann Ig; 2013; 25(3):235-46. PubMed ID: 23598807
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.